Pear Therapeutics, Inc. Warrant
PEARW
PEARW was delisted on the 18th of April, 2023.
2 hedge funds and large institutions have $277 invested in Pear Therapeutics, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 30 closing their positions.
94% less funds holding
Funds holding: 33 → 2 (-31)
100% less capital invested
Capital invested by funds: $709K → $277 (-$708K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 30
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$622K |
| 2 |
Walleye Capital
New York
|
-$24.5K |
| 3 |
DCM
Difesa Capital Management
New York
|
-$10.5K |
| 4 |
OCAM
Owl Creek Asset Management
New York
|
-$7.91K |
| 5 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Walleye Trading
New York
| – | -$203 | -10,643 | Closed |
|
|
LC
27
Littlejohn & Co
Greenwich,
Connecticut
| – | -$158 | -8,332 | Closed |
|
|
WTA
28
Washington Trust Advisors
Wellesley,
Massachusetts
| – | -$20 | -999 | Closed |
|
29
Morgan Stanley
New York
| – | -$14 | -740 | Closed |
|
PEARW Hedge Fund Activity: Q2 2023 in Review
2 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q2 2023, worth a combined $277 — down 100% from $709K a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of PEARW and 0 opened new positions — a net loss of 30 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $622K sold.
- 2 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q2 2023, down from 33 in Q1 2023.
- Funds reported $277 of Pear Therapeutics, Inc. Warrant stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Pear Therapeutics, Inc. Warrant positions in Q2 2023 and 30 closed out, a net change of -30 holders.
- The largest Pear Therapeutics, Inc. Warrant seller in Q2 2023 was LMR Partners, an estimated $622K sold.
Based on aggregated 13F filings for Q2 2023.